For many cases of treatment-resistant kidney disease, conventional medications fail to achieve desired results. In these situations, immunosuppressive drugs often become the “ultimate weapon”—powerful medications that can make the difference between progression and remission.
Immunosuppressive drugs are a class of medications that kidney patients must use with extreme caution, including:
- Corticosteroids that patients often fear: cortisone, prednisone, methylprednisolone, dexamethasone
- Classic immunosuppressants: cyclophosphamide, tacrolimus, cyclosporine, mycophenolate mofetil, leflunomide
- Hydroxychloroquine: originally an antimalarial drug, later used as an immunosuppressant
- Traditional medicine extracts: Tripterygium wilfordii (thunder god vine)
- Targeted monoclonal antibodies: rituximab, belimumab, and others
Due to significant side effects and high costs, these medications require careful consideration of risks versus benefits before use.
Which Kidney Patients Need Immunosuppressive Therapy?
Seven specific kidney conditions may require immunosuppressive treatment:
1. Minimal Change Disease
Immunosuppressants are essentially a cure for minimal change disease, achieving complete remission in over 90% of cases—nearly 100%. While patients must endure significant short-term side effects, these typically resolve after stopping the medication. The long-term benefits are substantial, making treatment highly recommended.
2. High-Risk Membranous Nephropathy
About one-third of membranous nephropathy cases resolve spontaneously without immunosuppression, and another third don’t respond significantly even with treatment. Only high-risk patients need immunosuppressive therapy:
- Protein in urine >8 grams per day
- Protein in urine >3.5 grams per day with declining kidney function
3. Recurrent Nephrotic Syndrome in FSGS
Focal segmental glomerulosclerosis (FSGS) shows limited response to immunosuppressants. About 60% of patients don’t achieve complete protein remission, and among the 40% who do respond, relapses are common. Additionally, repeat treatment may be ineffective.
FSGS should first be treated with conventional therapy: blood pressure control, cholesterol management, protein reduction, and blood clot prevention. Only patients with nephrotic syndrome (protein >3.5g/day, blood albumin <30g/L) who experience repeated relapses should consider immunosuppressive therapy.
4. Certain IgA Nephropathy Cases
IgA nephropathy requires immunosuppressive treatment when:
- Clinical indicators: Protein in urine remains >1 gram daily despite maximum ACE inhibitor/ARB therapy
- Biopsy findings: Significant inflammatory cell infiltration, mesangial cell proliferation, or cellular crescent formation
5. Certain Mesangial Proliferative Glomerulonephritis Cases
This condition more commonly causes heavy protein loss than IgA nephropathy. Patients presenting with nephrotic syndrome or significant active disease on biopsy should receive immunosuppressive treatment.
6. Lupus Nephritis
Lupus nephritis universally requires immunosuppressive therapy. Treatment approaches vary based on severity: low-dose steroids for mild cases, full-dose steroids for moderate cases, and combination steroid plus additional immunosuppressants for severe cases.
7. Certain Henoch-Schönlein Purpura Nephritis Cases
This condition has some potential for spontaneous healing, especially in children. Standard patients typically receive antihistamines, infection treatment, blood pressure control, and diuretics.
Immunosuppressive therapy is indicated when the condition presents as nephrotic syndrome, or when protein exceeds 1 gram daily with active proliferative changes on biopsy.
The Reality of “Ultimate Weapons”
When the decision to use immunosuppressive drugs arrives, other good options have usually been exhausted. This path is inherently challenging, potentially filled with obstacles, and doesn’t guarantee success.
However, this step isn’t the only option, nor is it necessarily the final destination. Multiple intervention strategies remain available. The challenge of chronic kidney disease must ultimately be overcome, requiring courage to cross to the other side.
Important Note: This information is for educational purposes only. All decisions about immunosuppressive therapy must be made in close consultation with qualified nephrologists who can evaluate your specific condition, assess risks and benefits, and provide appropriate monitoring during treatment.
发表回复